NCT01375244

Comparative Bioavailability Study of Lisinopril Tablets, 10 mg

Randomized, Open-label, Two-treatment Crossover, of a 10 mg Single Oral Dose, Study to Compare the Lisinopril Plasma Levels Produced After Administration of the Test Formulation With Those Produced After Administration of a Marketed Reference Product, Zestril(R), Under Fasting Conditions.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Par Pharmaceutical, Inc. · Industry
• Sex: Male
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the bioavailability of Par Lisinopril 10 mg Tablets and IPR Pharmaceuticals, Inc. Zestril (R).

Detailed description

To compare the bioavailability of Par and IPR (Zestril(R)), Lisinopril 10 mg Tablets under fasting conditions.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Lisinopril	Tablets, 10 mg, single dose
DRUG	Zestril	Tablets, 10 mg, single dose

Timeline

• Start date: 1999-06-01
• Primary completion: 1999-10-01
• Completion: 1999-10-01
• First posted: 2011-06-17
• Last updated: 2011-06-17

Locations

1 site across 1 country: United States